Skip to content
TrialScanner

NCT01508910

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Phase 3CompletedLSTALead

Registry record

Lead sponsor
Lisata Therapeutics, Inc.
Conditions
Chronic Myocardial Ischemia; Refractory Angina Pectoris; Advanced Coronary Heart Disease
Primary completion
Nov 2015Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01508910 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01508910: Efficacy and Safety of... | TrialScanner